Page last updated: 2024-11-08

guaiol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

guaiol: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID227829
CHEMBL ID226915
CHEBI ID5552
SCHEMBL ID114056
MeSH IDM0443331

Synonyms (51)

Synonym
[3s-(3alpha,5alpha,8alpha)]-1,2,3,4,5,6,7,8-octahydro-alpha,alpha,3,8-tetramethyl-5-azulenemethanol
2-[(3s,5r,8s)-3,8-dimethyl-1,2,3,4,5,6,7,8-octahydroazulen-5-yl]propan-2-ol
CHEBI:5552 ,
5-azulenemethanol, 1,2,3,4,5,6,7,8-octahydro-.alpha.,.alpha.,3,8-tetramethyl-, (3s,5r,8s)-
champaca camphor
champacol
guai-1(5)-en-11-ol
nsc19941 ,
nsc-19941
guaiac alcohol
5-azulenemethanol,2,3,4,5,6,7,8-octahydro-.alpha.,.alpha.,3,8-tetramethyl-, [3s-(3.alpha.,5.alpha.,8.alpha.)]-
BSPBIO_003320
489-86-1
guaiol
C09676
(-)-guaiol, 97%
KBIO3_002822
SPECTRUM3_001870
SPECTRUM1800009
NCGC00178142-01
CHEMBL226915
LMPR0103410007
nsc 19941
5-azulenemethanol, 1,2,3,4,5,6,7,8-octahydro-alpha,alpha,3,8-tetramethyl-, (3s,5r,8s)-
(-)-guaiol
unii-i7wp008a91
einecs 207-702-8
i7wp008a91 ,
2-((3s,8s)-1,2,3,4,5,6,7,8-octahydro-3,8-dimethylazulen-5-yl)propan-2-ol
guaiol [mi]
(3s,5r,8s)-1,2,3,4,5,6,7,8-octahydro-.alpha.,.alpha.3,8-tetramethyl-5-azulenemethanol
CCG-208248
SCHEMBL114056
guaiol(-)
mfcd00043336
(-)-guaiol, analytical standard
sr-05000002468
SR-05000002468-1
2-((3s,5r,8s)-3,8-dimethyl-1,2,3,4,5,6,7,8-octahydroazulen-5-yl)propan-2-ol
Q5613321
2-(3,8-dimethyl-1,2,3,4,5,6,7,8-octahydro-azulen-5-yl)-propan-2-ol
guaiol 100 microg/ml in acetonitrile
HY-N3980
CS-0024560
MS-23248
DTXSID40883399
E88593
(3r,6s,10s)-6,10,alpha,alpha-tetramethylbicyclo[5.3.0]dec-1(7)-ene-3-methanol
(3s-(3alpha,5alpha,8alpha))-1,2,3,4,5,6,7,8-octahydro-alpha,alpha,3,8-tetramethyl-5-azulenemethanol
(3s,5r,8s)-1,2,3,4,5,6,7,8-octahydro-alpha,alpha3,8-tetramethyl-5-azulenemethanol
AKOS040760436

Research Excerpts

Overview

Guaiol is a sesquiterpenoid found in many traditional Chinese medicines with potent antitumor activity.

ExcerptReferenceRelevance
"(-)-Guaiol is a sesquiterpenoid found in many traditional Chinese medicines with potent antitumor activity. "( (-)-Guaiol triggers immunogenic cell death and inhibits tumor growth in non-small cell lung cancer.
Gu, X; Ji, H; Miao, X; Shen, S; Tao, Y; Yang, J; Yang, X; Zang, H, 2023
)
2.03

Effects

ExcerptReferenceRelevance
"Guaiol has been used for thousands of years as a traditional Uygur medicine and is the primary active component found in Ferula ferulaeoides (Steud.) Korov (F. "( Determination and pharmacokinetic study of guaiol in rat plasma by gas chromatography-mass spectrometry with selected ion monitoring.
Ding, T; Hu, S; Li, K; Liu, H; Luo, J; Sheng, P; Yang, M, 2018
)
2.19

Pharmacokinetics

ExcerptReferenceRelevance
" This method was optimized for the quantification and pharmacokinetic analysis of guaiol in rat plasma following oral administration of chloroform extract from Ferula ferulaeoides."( Determination and pharmacokinetic study of guaiol in rat plasma by gas chromatography-mass spectrometry with selected ion monitoring.
Ding, T; Hu, S; Li, K; Liu, H; Luo, J; Sheng, P; Yang, M, 2018
)
0.97
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
guaiane sesquiterpenoid
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (6)

Assay IDTitleYearJournalArticle
AID286238Antibacterial activity against Salmonella typhi at 100 ug/100 uL after 24 hrs2007Journal of natural products, May, Volume: 70, Issue:5
Microbial transformation of (-)-guaiol and antibacterial activity of its transformed products.
AID286237Antibacterial activity against Pseudomonas aeruginosa at 100 ug/100 uL after 24 hrs2007Journal of natural products, May, Volume: 70, Issue:5
Microbial transformation of (-)-guaiol and antibacterial activity of its transformed products.
AID286235Antibacterial activity against Shigella flexneri at 100 ug/100 uL after 24 hrs2007Journal of natural products, May, Volume: 70, Issue:5
Microbial transformation of (-)-guaiol and antibacterial activity of its transformed products.
AID286233Antibacterial activity against Escherichia coli at 100 ug/100 uL after 24 hrs2007Journal of natural products, May, Volume: 70, Issue:5
Microbial transformation of (-)-guaiol and antibacterial activity of its transformed products.
AID286234Antibacterial activity against Bacillus subtils at 100 ug/100 uL after 24 hrs2007Journal of natural products, May, Volume: 70, Issue:5
Microbial transformation of (-)-guaiol and antibacterial activity of its transformed products.
AID1224817Assays to identify small molecules inhibitory for eIF4E expression2015Chemistry & biology, Jul-23, Volume: 22, Issue:7
Internal Ribosome Entry Site-Based Bicistronic In Situ Reporter Assays for Discovery of Transcription-Targeted Lead Compounds.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (19)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (5.26)18.2507
2000's4 (21.05)29.6817
2010's11 (57.89)24.3611
2020's3 (15.79)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.21

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.21 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index5.15 (4.65)
Search Engine Demand Index72.10 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.21)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]